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Summary
The microbiome co-evolved with its human host over a long time and became essential for many processes. 
Bacteria play a role in maintaining human health as they digest food, produce vitamins and participate in the 
regulation of metabolism. By influencing the cytokine balance along with the composition and activity of leu-
kocytes, they constantly interact with the immune system, affecting innate and adaptive immune homeostasis. 
A growing number of studies indicate that the microbiome in the human intestine may have an impact on the 
functions of the central nervous system (CNS), through identified pathways called the gut–brain axis. Recent 
data show that the human microbiome ecosystem interferes with the brain’s development, central signaling 
systems and behavior. It has been proposed that disruption in the human microbiome may affect the course 
of psychiatric disorders. The aim of this review is to summarize the recognized pathways of the gut–brain axis 
that have been thoroughly studied in animal models and to evaluate the role of the dialogue between the mi-
crobiota and the central nervous system in schizophrenia, bipolar disorder and depression.
microbiome/gut–brain axis/vagus nerve/neurotransmission/hypothalamic–pituitary–adrenal 
(HPA) axis
INTRODUCTION
The commensal bacteria microsystem in hu-
mans consists of 3.9 × 10^13 bacteria, indicating 
that the number of bacteria in our bodies repre-
sents the same order as the number of our eukar-
yotic cells [1]. A view that bacterial species ex-
ceed the number of human cell types up to five 
times has been accepted for a long time, howev-
er, recent work has debunked this notion. A new 
study suggests that the ratio of bacterial to hu-
man cells is approximately 1.3:1 [2]. Bacteria are 
transferred from the mother to the baby dur-
ing labor. The method of delivery, diet, drugs 
and medications (especially antibiotics) contrib-
ute to the process of microbiome development 
in the infant [3]. A 1-year-old child has eventu-
ally formed individual community of microor-
ganisms [4so too is a new microbial ecosystem, 
one that resides in that person’s gastrointesti-
nal tract. Although it is a universal and integral 
part of human biology, the temporal progression 
of this process, the sources of the microbes that 
make up the ecosystem, how and why it varies 
from one infant to another, and how the compo-
sition of this ecosystem influences human phys-
iology, development, and disease are still poor-
ly understood. As a step toward systematically 
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investigating these questions, we designed a mi-
croarray to detect and quantitate the small sub-
unit	ribosomal	RNA	(SSU	rRNA].	Bacteroidetes 
and Firmicutes are two bacterial phyla that ac-
count for the majority of intestinal microflora. 
Others, less prevalent, include Actinobacteria, Ar-
chaea, Fusobacteria, Proteobacteria, Verrucomicro-
bia. Apart from bacteria, the microbiota compris-
es fungi, protists and viruses, but in this paper 
we use this term referring only to bacteria. Al-
though a person’s microbiota constitutes a dis-
tinct, personal assembly, studies reveal that peo-
ple share commonalities in the composition of 
bacterial	populations.	Depending	on	the	pro-
portion of bacterial genera, the human popula-
tion can be divided into three enterotypes. En-
terotype I is dominated by Bacteroidetes, enter-
otype II is characterized by smaller amounts of 
Bacteroidetes but higher amounts of Prevotella, 
and enterotype III is characterized by the pres-
ence of Ruminococcus [5] but it is still based on 
very few cohorts and little is known about var-
iation across the world. By combining 22 newly 
sequenced faecal metagenomes of individuals 
from four countries with previously published 
data sets, here we identify three robust clusters 
(referred to as enterotypes hereafter).
The microbiome co-evolved with its human host 
over a long time and became essential for many 
processes. Bacteria play a role in maintaining hu-
man health as they digest food, produce vitamins 
and participate in metabolic regulation. By influ-
encing the cytokine balance along with the com-
position and activity of leukocytes, bacteria con-
stantly interact with the immune system, affecting 
the innate and adaptive immune homeostasis [6].
A growing number of studies indicate that the 
microbiome of the human intestine may have 
an impact on the functions of the central nerv-
ous	system	(CNS),	through	identified	pathways	
called the gut–brain axis. Recent data show that 
the human microbiome ecosystem interferes 
with the brain’s development, central signaling 
systems and behavior. It has been proposed that 
the disruption of the human microbiome may 
contribute to the aetiology and course of some 
psychiatric disorders [7].
The aim of this review is to summarize the rec-
ognized gut–brain axis pathways and to evalu-
ate their role in schizophrenia, bipolar disorder 
and depression.
THE INTERPLAY BETWEEN THE MICROBIOME 
AND THE HPA AXIS
Gut bacteria influence the brain by modulat-
ing the hypothalamic–pituitary–adrenal (HPA) 
axis, thus becoming a potent player participat-
ing in the body’s stress response. It has been 
shown that the development of the HPA axis is 
determined by postnatal microbial colonization 
[8].	Disturbances	in	HPA	axis	functioning	have	
been discovered in germ-free mice, alongside en-
hanced stress reactivity and impaired cognition 
[9]. However, this exaggerated acute stress re-
sponse in germ-free mice can be reverted with 
bacterial transplant from healthy mice [10]. This 
effect occurs in normally colonized organisms as 
well – increased gut permeability leads to bacte-
rial translocation that in turn results in HPA axis 
response and immune activation [11]. HPA axis 
reaction against acute stress may be ameliorat-
ed by probiotic treatment [12]. In rats early life 
stress (maternal separation) increases blood cor-
ticosterone levels and leads to immune activa-
tion as well as changes in gut microbiota [13]. 
However, this effect can also be reverted, as cor-
ticosterone release is normalized with probiot-
ic pre-treatment [14] – Lactobacillus is a probiot-
ic species found to be capable of reducing corti-
costerone levels [9]. In addition, early maternal 
separation is responsible for persisting changes 
in rats’ behavior, the HPA axis balance and gut 
microbiota, and Bifidobacterium infantis is anoth-
er probiotic species that has the ability to nor-
malize stress-related behavior [15]. One study 
has shown that Lactobacillus helveticus and Bifi-
dobacterium longum also have beneficial psycho-
logical effects that are paired with plasma corti-
sol	reduction	[16].	Not	only	can	stress-associat-
ed behavior be modified with the help of probi-
otic bacteria, but there is a possibility to induce 
whole phenotypes by means of a microbiota 
transplant. Anxious or non-anxious phenotype 
in mice may be obtained after transplantation of 
intestinal microorganisms from an animal with 
the same phenotype [17]. What is more, a dou-
ble-blind, randomized parallel group study re-
vealed that after 30 days of oral treatment with 
a probiotic formulation comprising Lactobacil-
lus helveticus R0052 and Bifidobacterium longum 
R0175 24-hour urinary free cortisol was lower 
than in the control group. Reduction of anxi-
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ety-like behavior in rats and alleviation of so-
cial distress in human volunteers have also been 
observed [18]a probiotic formulation (PF. Those 
findings indicate that gut bacteria are potent 
modulators	of	HPA	axis	in	the	long	run.	Schmidt	
et al. provide support for this hypothesis. They 
found that treatment with prebiotics, substances 
promoting the growth of beneficial bacteria, al-
ters the cortisol-awaking response and emotion-
al reaction in healthy human subjects [19]. Intes-
tinal bacteria can modulate the HPA axis indi-
rectly by acting on the vagus nerve, whose stim-
ulation leads to HPA axis activation [20].
Bacteria have a huge impact on the HPA axis 
but the association between neuroendocrine re-
actions and the microbiome is bidirectional. Of-
lactory bulbectomy-induced depression in mice 
leads to disturbances in the microbial profile. 
It was found that this model of depression and 
anxiety displays elevated corticotropin-releas-
ing factor (CRF) expression as well as increased 
c-Fos activity, serotonin levels and colon motili-
ty. Those changes are associated with an altered 
intestinal microbiome and with HPA activation 
[21].	Numerous	signaling	molecules	influence	
the composition of gut microbiome, including 
chemicals released from enteric neurons, entero-
chromaffin cells and vagal afferents. CRF, an ini-
tial neurohormone of HPA response, may shape 
bacterial population, taking into account that it 
may affect gut functions in multiple ways by act-
ing on the CRFR2 (corticotropin-releasing factor 
receptor 2), thus modulating stress-induced gut 
permeability, motility, immune and inflamma-
tory response [22,23].
THE IMMUNE-SYSTEM MEDIATED INTERACTIONS 
BETWEEN THE MICROBIOME AND THE BRAIN
Although the brain is a distant organ for in-
testinal bacteria, microorganisms that reside in 
the	gut	can	exert	their	influence	on	the	CNS	via	
the immune system, not to mention the fact that 
even	the	immune-privileged	CNS	appears	to	be	
persistently inhabited by innocuous alpha-pro-
teobacteria [24] Commensal microbiota modu-
lates the autoreactivity of immune cells against 
the central nervous system [25]. The microbi-
ome plays a role in the pathogenesis of numer-
ous immune-mediated disorders such as spon-
dyloarthritis, rheumatoid arthritis and even ex-
perimental autoimmune encephalitis. Germ-free 
mice are resistant to those diseases [26] and their 
immune cells do not normally express toll-like 
receptors (TLR) – their lack makes an adequate 
immune and neuroendocrine response impossi-
ble	[27]	Studies	using	TLR4	knockout	mice	sup-
port the notion that the immune system is one 
of the key moderators participating in the di-
alogue between the brain and gut bacteria as 
TLR4 knockout mice do not respond with HPA 
axis activation after administration of gram-neg-
ative bacteria [28].
Treatment with probiotics acts on the brain 
through the immune system. Cytokines are po-
tent regulators of brain functioning. Peripher-
ally produced pro-inflammatory cytokines like 
interleukins IL–1 and IL–6 can induce sickness 
behavior. Recent studies highlighted the role of 
cytokines in the pathogenesis of depression, bi-
polar disorder and schizophrenia. Gut bacte-
ria affect the immune balance of its host so they 
may have an impact on brain functioning. Bifi-
dobacterium infantis is one of the probiotic bac-
teria found to be capable of altering the profile 
of pro- and anti-inflammatory cytokines [29] In 
one study, probiotic bacteria Lactobacillus helve-
ticus prevented mice on a high-fat diet from de-
veloping anxious and depressive behavior, how-
ever, this effect was not observed in the group of 
immunocompromised	mice	[30].	Unsurprising-
ly, interactions between the immune system, gut 
microbiota	and	the	brain	are	bidirectional.	So-
cial disruption changes the microbiome and the 
immune system functions as an intermediary. 
Bailey et al. have shown that the composition of 
murine intestinal bacteria changes along with al-
terations in cytokine levels after repeated stress 
exposure [31]however, is not well understood. 
To determine whether the microbiome contrib-
utes to stressor-induced immunoenhancement, 
mice were exposed to a social stressor called so-
cial	disruption	(SDR.
THE MICROBIOME AND NEUROTRASMISSION
An intriguing aspect of brain–gut studies is the 
question of how the microbiome interferes with 
the neurotransmitters system. Interestingly, gut 
microorganisms have been shown to have an 
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ability to synthesize neurotransmitters and neu-
romodulators. Both Lactobacillus and Bifidobacte-
ria species have been shown to produce gamma-
aminobutyric acid (GABA), Escherichia, Bacillus 
has been shown to synthesize norepinephrine 
(NE),	Lactobacillus can produce acetylcholine, 
Streptococcus, Escherichia and Enterococcus pro-
duce 5-HT (5-hydroxytryptamine – serotonin), 
while Bacillus	can	synthesize	dopamine	(DA)	
[32,33]. It has been proposed that those neuro-
transmitters released into the intestinal lumen 
may stimulate epithelial cells to release modu-
lators affecting neurotransmission within the en-
teric	nervous	system	(ENS)	or	acting	directly	on	
primary afferent axons [6,34].
Moreover, it has been shown that the micro-
biome	can	affect	the	CNS	directly	via	the	vagus	
nerve. Bravo et al. have shown that sustained 
treatment with probiotic bacteria, Lactobacil-
lus rhamnosus (JB–1), induced alterations in the 
GABAergic system in mice. It induced region-
dependent	changes	in	GABAB1b	mRNA	in	the	
brain, with an increase in the cingulate and pre-
limbic regions and concomitant reduction of its 
expression in the hippocampus, amygdala and 
locus coeruleus. Additionally, it has decreased 
GABAAalpha2	mRNA	expression	in	the	pre-
frontal cortex and amygdala and increased its 
expression in the hippocampus. Changes were 
associated with a reduction of stress-induced 
corticosterone as well as anxiety and depres-
sion-related behavior. Interestingly, vagotomy 
prevented behavioral and neurochemical effects 
of Lactobacillus rhamnosus (JB–1) [35]. Our exper-
imental data have shown that vagus nerve stim-
ulation influences the physiology of the dopa-
minergic system, so if probiotic bacteria modu-
late the vagus nerve, it may also have an impact 
on dopamine-related brain regions [36]. Heijtz et 
al. have shown that germ-free mice present el-
evated dopamine turnover in the striatum and 
this alteration is associated with their hyperac-
tive phenotype [37]many of which are associated 
with immunity and nutrient intake. Here, we re-
port that colonization by gut microbiota impacts 
mammalian brain development and subsequent 
adult	behavior.	Using	measures	of	motor	activ-
ity and anxiety-like behavior, we demonstrate 
that	germ	free	(GF.	Studies	on	germ-free	mice	
have also shown disruption of the hippocam-
pal serotonergic system associated with elevat-
ed levels of serotonin and its metabolites [38]
including	that	of	the	CNS.	However,	there	is	a	
paucity of data pertaining to the influence of mi-
crobiome on the serotonergic system. Germ-free 
(GF. Interestingly, this murine model also pre-
sents hippocampal-dependent memory impair-
ments [9]. The abovementioned data indicate 
that large intestine microbiome influences brain 
development, neurotransmitters systems, cog-
nitive functioning and behavior. Thus, search-
ing for associations between the microbiome and 
mental health appears to be justified.
Schizophrenia, bipolar disorder and the 
microbiome
Studies	have	identified	an	association	between	
schizophrenia and microbiome disruption [39]. 
The	research	of	Severance	et	al.	[40],	measuring	
markers of intestinal inflammation and bacterial 
translocation, uncovered the presence of struc-
tural damage to the gastrointestinal barrier in 
schizophrenia patients. Patients with recent-on-
set as well as chronic schizophrenia present el-
evated levels of antibodies against commensal 
fungus – Saccharomyces cerevisiae [40]. Autopsy 
findings show a structural damage in the gastro-
intestinal system of individuals with schizophre-
nia. Intriguingly, among 82 patients with schiz-
ophrenia in a study by Hemmings, 92% had co-
litis, 88% enteritis and 50% gastritis [41]. Mice 
models displaying features of schizophrenic be-
havior, after treatment using the human com-
mensal (Bacteroides fragilis), presented correct-
ed gut permeability, altered microbial compo-
sition and ameliorated defects in communica-
tive, stereotypic, anxiety-like and sensorimotor 
behaviors [42].
Colonic bacteria of patients with short bow-
el	syndrome	have	been	shown	to	form	D-lactic	
acid from unabsorbed carbohydrates. Accumu-
lation of this acid in the blood causes cognitive 
dysfunction and ataxia symptoms [43] Fukush-
ima et al. have shown that increased levels of 
D-lactate	were	one	of	the	major	contributors	to	
the discrimination between controls and schiz-
ophrenia patients [44]. Thus, in future studies, 
it may be viable to evaluate whether an increase 
of	D-lactate	in	schizophrenia	may	be	associated	
with microbiota disruptions.
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The microbiome may have an impact on in-
ducing weight gain in schizophrenia patients af-
ter antipsychotic treatment. Olanzapine admin-
istration evoked significant changes in the bac-
terial phyla of the gut in female rats, resulting 
in an increase of Firmicutes and decrease of Bac-
teroides. Those changes were associated with in-
creased markers of systemic inflammations in-
cluding interleukins Il–6, Il–8, tumor necrosis 
factor	alpha	(TNF-α)	and	IL–1β.
Immunological dysregulation and dispropor-
tion of the inflammatory/anti-inflammatory cy-
tokines balance have been noted both in schizo-
phrenia and bipolar disorder. An altered micro-
biome may result in dysregulation of immuno-
logical homeostasis, and thus it may contribute 
to the development of both mental disorders 
[45].	Similarly	to	patients	with	schizophrenia,	
patients with bipolar disorder present with ele-
vated antibodies against commensal Saccharomy-
ces cerevisiae, indicating an increased immuno-
logical response against intestinal antigens [46]. 
Moreover, both groups of patients present ele-
vated	serum	levels	of	the	soluble	form	of	CD14	
protein, which is a surrogate of bacterial trans-
location marker [47]. The putative role of the mi-
crobiome in bipolar disorder is supported by the 
case of a successful treatment of a 21-year-old 
patient with bipolar disorder using a special nu-
trition formula [48]. The authors suspect that the 
positive effects of the treatment were associated 
with its effect on the intestinal microflora [48]. 
Recently, a case has been presented of a resolu-
tion of a manic episode followed by treatment 
targeted on the brain–gut axis [49].
DEPRESSION AND THE MICROBIOME
A growing body of research points to the ma-
jor role of low-grade inflammation in the patho-
physiology	of	depression.	Disturbances	of	mi-
crobiota and its association with its host have re-
cently become another new pathway suspected 
of inducing inflammatory response in depres-
sion [50]. Jiang et al. have shown that microbi-
ome disturbances exist in patients with depres-
sion. In particular, patients are characterized by 
an overrepresentation of bacteria from Enterobac-
teriaceae family and Alistipes genus. Interestingly, 
a negative correlation has been found between 
depressive symptoms and the amount of Faecal-
ibacterium [51]. It has been shown that clinical 
depression is accompanied by elevated levels of 
immunoglobulin A and/or M against gram-neg-
ative bacteria belonging to human gut microflo-
ra [52,53], such as: Hafnia alvei, Pseudomonas aer-
uginosa, Morganella morganii, Proteus mirabilis, 
Pseudomonas putida, Citrobacter koseri or Klebsiel-
la pneumoniae [50,54,55]. An inflammatory reac-
tion of the body against lipopolysaccharide in 
the outer membrane of gram-negative bacteria 
and bacterial translocation were proposed as 
key factors that participate in the development 
of clinical depression [56].
CONCLUSIONS
The data indicate an association between large 
intestine microbiome and central nervous sys-
tem functioning in humans. Research on pa-
tients with bipolar disorder, unipolar depres-
sion and schizophrenia as well as animal studies 
identified microbiome disruption in those enti-
ties. The studies presented here provide the ba-
sis for a careful analysis of mutual interactions 
between the microbiome and the gut–brain axis 
that should be performed to determine the role 
of those interactions in the pathogenesis of men-
tal disorders. Awareness of the significance of 
those mechanisms may lead to a future search 
for new therapeutic interventions focused on the 
gut–brain axis in schizophrenia, bipolar disorder 
and unipolar depression.
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